ASMase knockout (ASMase−/−) and wild-type (WT) mice bearing fibrosarcoma (MCA/129 tumour line) were treated with 10 Gy or 20 Gy in five fractions alongside or independently of USMB treatments. This evidence concerns the gene SMPD1 and fibrosarcoma.